Functions and mechanisms of microRNA-31 in human cancers.

[1]  Xiangyan Ruan,et al.  The Dual Regulatory Role of MiR-181a in Breast Cancer , 2017, Cellular Physiology and Biochemistry.

[2]  Long-Bang Chen,et al.  Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma , 2017, Journal of experimental & clinical cancer research : CR.

[3]  C. Lengner,et al.  MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists , 2017, Nature Communications.

[4]  C. Lengner,et al.  Stress responsive miR-31 is a major modulator of mouse intestinal stem cells during regeneration and tumorigenesis , 2017, eLife.

[5]  Z. Madjd,et al.  MicroRNA-31 inhibits RhoA-mediated tumor invasion and chemotherapy resistance in MKN-45 gastric adenocarcinoma cells , 2017, Experimental biology and medicine.

[6]  Hongli Li,et al.  Dock1 promotes the mesenchymal transition of glioma and is modulated by MiR‐31 , 2017, Neuropathology and applied neurobiology.

[7]  Sergio Araujo,et al.  Evaluation of MiR-15a and MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[8]  Takashi Takahashi,et al.  Thyroid transcription factor‐1‐regulated microRNA‐532‐5p targets KRAS and MKL2 oncogenes and induces apoptosis in lung adenocarcinoma cells , 2017, Cancer science.

[9]  K. Cadigan.  Faculty of 1000 evaluation for Stem cell signaling. An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control. , 2017 .

[10]  Long-Bang Chen,et al.  The Versatile Role of microRNA-30a in Human Cancer , 2017, Cellular Physiology and Biochemistry.

[11]  V. Georgoulias,et al.  Targeting KRAS mutated non-small cell lung cancer: A history of failures and a future of hope for a diverse entity. , 2017, Critical reviews in oncology/hematology.

[12]  N. Lin,et al.  MicroRNA-31 functions as an oncogenic microRNA in cutaneous squamous cell carcinoma cells by targeting RhoTBT1 , 2017, Oncology letters.

[13]  Su-jin Yang,et al.  MiR-31 inhibits migration and invasion by targeting SATB2 in triple negative breast cancer. , 2016, Gene.

[14]  Yuan Xia,et al.  MiR-31 Regulates Rho-Associated Kinase-Myosin Light Chain (ROCK-MLC) Pathway and Inhibits Gastric Cancer Invasion: Roles of RhoA , 2016, Medical science monitor : international medical journal of experimental and clinical research.

[15]  H. Akça,et al.  Downregulation of SATB2 is critical for induction of epithelial-to-mesenchymal transition and invasion of NSCLC cells. , 2016, Lung cancer.

[16]  Runsheng Li,et al.  The dual regulatory role of miR-204 in cancer , 2016, Tumor Biology.

[17]  Guoqing Wang,et al.  Downregulated miR-31 level associates with poor prognosis of gastric cancer and its restoration suppresses tumor cell malignant phenotypes by inhibiting E2F2 , 2016, Oncotarget.

[18]  Rui Zhang,et al.  MicroRNA-31 inhibits lung adenocarcinoma stem-like cells via down-regulation of MET-PI3K-Akt signaling pathway. , 2016, Anti-cancer agents in medicinal chemistry.

[19]  N. Petrović.  miR-21 Might be Involved in Breast Cancer Promotion and Invasion Rather than in Initial Events of Breast Cancer Development , 2016, Molecular Diagnosis & Therapy.

[20]  O. Kent,et al.  Transcriptional Regulation of miR-31 by Oncogenic KRAS Mediates Metastatic Phenotypes by Repressing RASA1 , 2016, Molecular Cancer Research.

[21]  Xuebin Zhang,et al.  Upregulation of microRNA-31 targeting integrin α5 suppresses tumor cell invasion and metastasis by indirectly regulating PI3K/AKT pathway in human gastric cancer SGC7901 cells , 2016, Tumor Biology.

[22]  M. Nagino,et al.  SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer , 2015, Oncotarget.

[23]  Zhongming Zhao,et al.  MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer. , 2015, The Journal of clinical investigation.

[24]  C. Croce,et al.  Repression of Esophageal Neoplasia and Inflammatory Signaling by Anti-miR-31 Delivery In Vivo. , 2015, Journal of the National Cancer Institute.

[25]  Z. Tengteng,et al.  Tumor suppressor microRNA-31 inhibits gastric carcinogenesis by targeting Smad4 and SGPP2 , 2015, Cancer Gene Therapy.

[26]  Keisuke Uehara,et al.  SATB2 suppresses the progression of colorectal cancer cells via inactivation of MEK5/ERK5 signaling , 2015, The FEBS journal.

[27]  Suk Woo Nam,et al.  MicroRNA-31 functions as a tumor suppressor by regulating cell cycle and epithelial-mesenchymal transition regulatory proteins in liver cancer , 2015, Oncotarget.

[28]  R. Nusse,et al.  An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control , 2014, Science.

[29]  Y. Miyagi,et al.  A comprehensive search for microRNAs with expression profiles modulated by oncogenic KRAS: potential involvement of miR-31 in lung carcinogenesis. , 2014, Oncology reports.

[30]  Shu-Chun Lin,et al.  EGF Up-Regulates miR-31 through the C/EBPβ Signal Cascade in Oral Carcinoma , 2014, PloS one.

[31]  K. Choy,et al.  miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis , 2014, Molecular Cancer.

[32]  Hui Li,et al.  MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A. , 2014, Gynecologic oncology.

[33]  Shu-Chun Lin,et al.  miR-31 is upregulated in oral premalignant epithelium and contributes to the immortalization of normal oral keratinocytes. , 2014, Carcinogenesis.

[34]  J. Xu,et al.  A systematic analysis of predicted MiR-31-targets identifies a diagnostic and prognostic signature for lung cancer. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[35]  S. Poulsen,et al.  Expression of the EGF Family in Gastric Cancer: Downregulation of HER4 and Its Activating Ligand NRG4 , 2014, PloS one.

[36]  Jiake Xu,et al.  The role of SATB2 in skeletogenesis and human disease. , 2014, Cytokine & growth factor reviews.

[37]  Shuang Wang,et al.  Elevated MicroRNA-31 Expression Regulates Colorectal Cancer Progression by Repressing Its Target Gene SATB2 , 2013, PloS one.

[38]  A. Kallioniemi,et al.  The diverse role of miR‐31 in regulating cancer associated phenotypes , 2013, Genes, chromosomes & cancer.

[39]  Wei Huang,et al.  miR-31 promotes oncogenesis in intrahepatic cholangiocarcinoma cells via the direct suppression of RASA1 , 2013, Experimental and therapeutic medicine.

[40]  C. Croce,et al.  MicroRNA-31 Predicts the Presence of Lymph Node Metastases and Survival in Patients with Lung Adenocarcinoma , 2013, Clinical Cancer Research.

[41]  Richard Tighe,et al.  Canonical Wnt signals combined with suppressed TGFβ/BMP pathways promote renewal of the native human colonic epithelium , 2013, Gut.

[42]  H. Watari,et al.  Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET , 2013, Oncogenesis.

[43]  Francesca Demichelis,et al.  Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression. , 2013, Cancer research.

[44]  Stefan Wiemann,et al.  MicroRNA-31 Sensitizes Human Breast Cells to Apoptosis by Direct Targeting of Protein Kinase C ϵ (PKCϵ)* , 2013, The Journal of Biological Chemistry.

[45]  X. Chen,et al.  MicroRNA-31 Activates the RAS Pathway and Functions as an Oncogenic MicroRNA in Human Colorectal Cancer by Repressing RAS p21 GTPase Activating Protein 1 (RASA1)* , 2013, The Journal of Biological Chemistry.

[46]  C. Croce,et al.  Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer. , 2012, Carcinogenesis.

[47]  N. Lynam‐Lennon,et al.  MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma , 2012, Journal of Molecular Medicine.

[48]  J. Pouysségur,et al.  The asparaginyl hydroxylase factor-inhibiting HIF is essential for tumor growth through suppression of the p53–p21 axis , 2012, Oncogene.

[49]  M. Uhlén,et al.  A cohort study of the prognostic and treatment predictive value of SATB2 expression in colorectal cancer , 2012, British Journal of Cancer.

[50]  C. Galbán,et al.  Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice. , 2012, The Journal of clinical investigation.

[51]  J. Eun,et al.  Aberrant Regulation of HDAC2 Mediates Proliferation of Hepatocellular Carcinoma Cells by Deregulating Expression of G1/S Cell Cycle Proteins , 2011, PloS one.

[52]  Chunxiang Zhang,et al.  MicroRNA-31 Regulated by the Extracellular Regulated Kinase Is Involved in Vascular Smooth Muscle Cell Growth via Large Tumor Suppressor Homolog 2* , 2011, The Journal of Biological Chemistry.

[53]  Fang Zhou,et al.  A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis , 2011, Clinical Cancer Research.

[54]  K. Sossey-Alaoui,et al.  miR-31 Is a Broad Regulator of β1-Integrin Expression and Function in Cancer Cells , 2011, Molecular Cancer Research.

[55]  Lan Xu,et al.  miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells* , 2010, The Journal of Biological Chemistry.

[56]  E. Dmitrovsky,et al.  MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. , 2010, The Journal of clinical investigation.

[57]  P. Gunaratne,et al.  Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. , 2010, Cancer research.

[58]  S. Chiou,et al.  miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. , 2010, Cancer research.

[59]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[60]  H. Varmus,et al.  Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. , 2001, Genes & development.

[61]  Hai-tao Xu,et al.  MiR-31 Functions as a Tumor Suppressor in Lung Adenocarcinoma Mainly by Targeting HuR. , 2016, Clinical laboratory.

[62]  Brigitte M Pützer,et al.  The E2F1-miRNA cancer progression network. , 2013, Advances in experimental medicine and biology.

[63]  K. Al-Kuraya,et al.  HGF/c-Met pathway has a prominent role in mediating antiapoptotic signals through AKT in epithelial ovarian carcinoma , 2011, Laboratory Investigation.

[64]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.